Home » Topics » Regulatory » Patents

Patents
RSS

Neuroprotective agents based on enzyme inhibition prepared at P&U

June 11, 1998

Pfizer team reveals heterobicyclic CRF antagonists

June 11, 1998

Novel rapamycin derivatives patented by AHP

June 11, 1998

Warner-Lambert team describes preferential inhibitors of MMP-2 and MMP-3

June 11, 1998

New antiallergic and antiinflammatory compounds developed by Astra researchers

June 11, 1998

Pfizer discloses indazole inhibitors of PDE and TNF production

June 11, 1998

Crambescidin 816, an antiviral and antitumor agent from a marine sponge

June 10, 1998

AHP reports dopamine autoreceptor agonists with antipsychotic potential

June 10, 1998

Antitumor, antifungal cryptophycins developed by U.S. pharmaceutical/academic team

June 9, 1998

Byk Gulden patents another series of thiazole PDE IV inhibitors

June 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld Science
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...